Literature DB >> 2480260

Renal epithelial fluid secretion and cyst growth: the role of cyclic AMP.

R Mangoo-Karim1, M E Uchic, M Grant, W A Shumate, J P Calvet, C H Park, J J Grantham.   

Abstract

Transepithelial fluid secretion has been postulated to account for the accumulation of fluid within hereditary and acquired renal cysts, but no such mechanism has been demonstrated in human kidney epithelium. It is shown here that transepithelial fluid secretion was stimulated by prostaglandin E1 (PGE1), forskolin, 8-Br-cyclic AMP, and 1-methyl-3-isobutylxanthine in polarized monolayers of established renal cell lines (MDCK and rat glomerular epithelial cells) and in monolayer cultures derived from the cyst walls of human autosomal dominant polycystic kidney disease and from epithelial cells of normal human renal cortex. Treatment with cyclic AMP agonists caused the same cells, when dispersed within a gel matrix of type I collagen (Vitrogen), to proliferate and form spherical fluid-filled monolayered cysts. Our findings suggest that increased intracellular cyclic AMP levels may have a critical role in the formation and expansion of hereditary and acquired renal cysts.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2480260     DOI: 10.1096/fasebj.3.14.2480260

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  35 in total

1.  Green mamba peptide targets type-2 vasopressin receptor against polycystic kidney disease.

Authors:  Justyna Ciolek; Helen Reinfrank; Loïc Quinton; Say Viengchareun; Enrico A Stura; Laura Vera; Sabrina Sigismeau; Bernard Mouillac; Hélène Orcel; Steve Peigneur; Jan Tytgat; Laura Droctové; Fabrice Beau; Jerome Nevoux; Marc Lombès; Gilles Mourier; Edwin De Pauw; Denis Servent; Christiane Mendre; Ralph Witzgall; Nicolas Gilles
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-19       Impact factor: 11.205

Review 2.  ADPKD: molecular characterization and quest for treatment.

Authors:  Shigeo Horie
Journal:  Clin Exp Nephrol       Date:  2005-12       Impact factor: 2.801

3.  Polycystin-1, 2, and STIM1 interact with IP(3)R to modulate ER Ca release through the PI3K/Akt pathway.

Authors:  Netty G Santoso; Liudmila Cebotaru; William B Guggino
Journal:  Cell Physiol Biochem       Date:  2011-06-17

4.  Polycystin-2 and phosphodiesterase 4C are components of a ciliary A-kinase anchoring protein complex that is disrupted in cystic kidney diseases.

Authors:  Yun-Hee Choi; Akira Suzuki; Sachin Hajarnis; Zhendong Ma; Hannah C Chapin; Michael J Caplan; Marco Pontoglio; Stefan Somlo; Peter Igarashi
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-13       Impact factor: 11.205

5.  Apical plasma membrane mispolarization of NaK-ATPase in polycystic kidney disease epithelia is associated with aberrant expression of the beta2 isoform.

Authors:  P D Wilson; O Devuyst; X Li; L Gatti; D Falkenstein; S Robinson; D Fambrough; C R Burrow
Journal:  Am J Pathol       Date:  2000-01       Impact factor: 4.307

6.  Fluid and electrolyte transport by cultured human airway epithelia.

Authors:  J J Smith; M J Welsh
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

7.  Dose-Titrated Vasopressin V2 Receptor Antagonist Improves Renoprotection in a Mouse Model for Autosomal Dominant Polycystic Kidney Disease.

Authors:  Debbie Zittema; Irina B Versteeg; Ron T Gansevoort; Harry van Goor; Emile de Heer; Kimberley A M Veraar; Dorien J M Peters; Esther Meijer
Journal:  Am J Nephrol       Date:  2016-08-31       Impact factor: 3.754

8.  Small-molecule CFTR inhibitors slow cyst growth in polycystic kidney disease.

Authors:  Baoxue Yang; Nitin D Sonawane; Dan Zhao; Stefan Somlo; A S Verkman
Journal:  J Am Soc Nephrol       Date:  2008-04-02       Impact factor: 10.121

Review 9.  Tissue-engineered kidney disease models.

Authors:  Teresa M Desrochers; Erica Palma; David L Kaplan
Journal:  Adv Drug Deliv Rev       Date:  2013-12-17       Impact factor: 15.470

10.  Emerging evidence of a link between the polycystins and the mTOR pathways.

Authors:  Alessandra Boletta
Journal:  Pathogenetics       Date:  2009-10-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.